National Association of Testing Authorities, Australia
Scope of Accreditation
Hong Kong Sanatorium and Hospital
Site
Department of Pathology
Accreditation No.
17248
Site No.
18921
Date of Accreditation
01 Jun 2017
Address
1/F Li Shu Fan Block, Hong Kong Sanatorium and Hospital, 2 Village Road, HAPPY VALLEY
0
Hong Kong
Contact
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
Withdrawn
Blood Bank
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Blood group antibody detection | Blood | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test) |
| Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies | ||
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood; Plasma | Other blood group antibodies; Red blood cell phenotyping; Rh |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood products | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood products | Issue and release of blood and blood products for transfusion |
Clinical Chemistry
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Sirolimus; Tacrolimus |
| Serum | Amikacin; Digoxin; Phenytoin (dilantin); Valproate (valproic acid, epilim); Vancomycin | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma | Human chorionic gonadotropin (hCG); α-Fetoprotein (AFP) |
| Serum | β2-Microglobulin (B2M) | |
| Thyroglobulin | ||
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free; Prostate specific antigen (PSA) fractions and derived index | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Progesterone; Prolactin |
| Adrenocorticotropic hormone (ACTH); Cortisol; Insulin | ||
| Parathyroid hormone (PTH) | ||
| Plasma; Serum | Dehydroepiandrosterone sulfate (DHEAS) | |
| Serum | Growth hormone; Testosterone | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Blood | Creatine kinase MB (CKMB); N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin I |
| Plasma | Creatine kinase MB (CKMB); N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin T | |
| Serum | Troponin I | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma | HDL - Quantitation |
| Serum | Apolipoprotein A; Apolipoprotein B | |
| Lipoprotein subclasses | ||
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma | Magnesium; Phosphate; Uric acid |
| Serum | Tryptase | |
| Haptoglobins; Prealbumin | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Blood | Bilirubin |
| Serum | Myoglobin | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Albumin |
| Glucose; Protein - Total | ||
| Cerebrospinal fluid (CSF); Serum | Lactate | |
| Other body fluids | Amylase; Creatinine; Lactate dehydrogenase (LDH); Sodium; Urea | |
| Plasma | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Conjugated; Bilirubin - Total; C-reactive protein (CRP); Calcium - Corrected for albumin; Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Magnesium; Phosphate; Phosphorus; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Plasma; Urine | Osmolality | |
| Serum | Soluble transferrin receptor (sTFR) | |
| High sensitivity C-reactive protein (CRP) | ||
| Urine | Microalbumin | |
| Amylase; Calcium - Total; Chloride; Creatinine; Phosphate; Phosphorus; Potassium; Protein - Total; Sodium; Urea | ||
| Chemical pathology - Investigation for folate deficiency | Blood; Plasma | Folate; Red blood cell folate |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Plasma | α-Fetoprotein (AFP) |
| Chemical pathology - Iron studies | Plasma | Ferritin; Iron; Total iron-binding capacity (TIBC) |
| Chemical pathology - Markers of bone metabolism | Plasma | Procollagen type 1 N-terminal propeptide (P1NP); β-Crosslaps (CTX) |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Methaemoglobin (MetHb); Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Homocysteine |
| Amino acids | ||
| Chemical pathology - Quantitation of vitamins | Plasma | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Plasma | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Serum | Thyroxine (T4) - Total; Triiodothyronine (T3) - Total | |
| Thyroxine (T4) - Free; Triiodothyronine (T3) - Free | ||
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | D-dimer |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Rheumatoid factor |
| Anti-thyroglobulin antibodies (Tg) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens)) | Serum | Ara h1 - Peanut; Ara h2 - Peanut; Ara h3 - Peanut; Ara h8 - Peanut; Ara h9 - Peanut; Peanut specific IgE; Peanut specific IgG; Peanut specific IgG4 |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Cat dander; Cat epithelium; Dog dander; Goose feathers; Horse dander |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Egg |
| Chicken; Egg; Egg white; Egg yolk; Turkey meat | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Blue mussel; Clam; Codfish; Crab; Crayfish; Lobster; Mackerel; Octopus; Plaice; Salmon; Sardine (pilchard); Scallop; Seafood mix; Shrimp; Sole; Squid; Swordfish; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Celery; Garlic; Kiwi; Onion; Pumpkin; Tomato |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Pork; Rabbit |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Milk |
| Cow milk | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Chocolate; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Soy bean |
| Almond; Brazil nut; Cashew nut; Coconut; Corn; Hazelnut; Macadamia nut; Maize; Oat; Peanut; Pecan nut; Pinenut; Pumpkin seed; Rice; Rye; Sesame seed; Soy bean; Sunflower seed; Walnut; Wheat | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bermuda grass; Cultivated rye; Perennial rye grass; Sweet vernal grass; Timothy grass; Wild rye grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | Cockroach; Mosquito |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Aspergillus fumigatus; Candida albicans; Cladosporium herbarum; Setomelanomma rostrata (Helminthosporium halodes); Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Alder; American beech; Elm; Eucalyptus; Grey alder; Hazel; Maple leaf sycamore; Oak; Olive; Silver birch; Tree mix; Willow salix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Honey bee venom |
| Venom component | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Giant ragweed; Western ragweed |
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum; Urine | Detection and quantitation of free kappa and free lambda light chains |
| Characterisation of paraproteins; Detection and amount of paraproteins; Detection of Bence Jones proteins; Immunoglobulin A (IgA) - Kappa; Immunoglobulin A (IgA) - Lambda; Immunoglobulin D (IgD) - Kappa; Immunoglobulin D (IgD) - Lambda; Immunoglobulin E (IgE) - Kappa; Immunoglobulin E (IgE) - Lambda; Immunoglobulin G (IgG) - Kappa; Immunoglobulin G (IgG) - Lambda; Immunoglobulin M (IgM) - Kappa; Immunoglobulin M (IgM) - Lambda; Monoclonal proteins; Protein classes; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | ||
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Cerebrospinal fluid (CSF) | Total immunoglobulin G |
| Serum | Total immunoglobulin E | |
| Immunoglobulin subclasses; Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Serum | Human chorionic gonadotropin (hCG) |
| Infertility and pregnancy tests including assisted reproductive technology - Infertility (including in-vitro fertilisation) related endocrinology | Plasma | Oestradiol |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Syphilis Treponema pallidum antibody |
| Cytomegalovirus (CMV); Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus (HBV); Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Quantitative; Hepatitis C virus (HCV); Hepatitis C virus antibody (anti-HCV) - Total; Human immunodeficiency virus (HIV); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Rubella IgM antibody |
Haematology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Examination of aspirated material | ||
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH) |
| Examination of haemoglobin H (HbH) | ||
| Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation | ||
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Malaria | ||
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean corpuscular volume (MCV); Platelet count; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Heparin assay; International normalised ratio (INR); Von Willebrand factor (vWF); Von Willebrand factor (vWF) antigen - Quantitation |
| Activated protein C (APC) resistance; Anti-thrombin III; Factor IX; Factor VIII; Lupus anticoagulant; Protein C and protein S | ||
| Platelet function (PFA) | ||
| Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; Prothrombin time (PT); Thrombin time (TT) | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Histopathology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Cervical tissue | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Endometrial pipelle | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Review and reporting of biopsy material to identify or exclude morphological abnormalities | ||
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Smears; Tissue imprint | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Fixed cytological smears; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
Immunology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA) |
| Anti-EJ antibodies; Anti-Jo-1 antibodies; Anti-Ku antibodies; Anti-La antibodies; Anti-Mi-2 antibodies; Anti-NOR 90 antibodies; Anti-NXP2 antibodies; Anti-OJ antibodies; Anti-PL-12 antibodies; Anti-PL-7 antibodies; Anti-Pm/Scl antibodies; Anti-Pm/Scl-100 antibodies; Anti-Pm/Scl-75 antibodies; Anti-RNA polymerase III - RP11, RP155; Anti-Ro antibodies; Anti-Ro-52 antibodies; Anti-SUMO activating enzyme antibodies (SAE); Anti-Scl-70 antibodies; Anti-Smith antibodies (Sm); Anti-centromere protein A antibodies (Cenp-A); Anti-centromere protein B antibodies (Cenp-B); Anti-double stranded DNA antibodies (dsDNA); Anti-fibrillarin antibodies; Anti-histone antibodies (AHA); Anti-melanoma differentiation associated gene 5 antibodies (MDA5); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-nucleosome antibodies; Anti-platelet derived growth factor (PDGF); Anti-proliferating cell nuclear antigen (PCNA); Anti-ribonucleoprotein antibodies (RNP); Anti-ribosomal P protein antibodies; Anti-signal recognition particle antibodies (SRP); Anti-transcription intermediary factor antibodies (TIF1); Anti-tyrosine hydroxylase antibodies (Th/To) | ||
| Anti-Pm/Scl antibodies; Anti-cardiolipin antibodies (ACA); Anti-cyclic citrullinated peptide antibodies (CCP); Anti-double stranded DNA antibodies (dsDNA); Anti-extractable nuclear antigen antibodies (ENA); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-thyroid peroxidase antibodies (TPO); Anti-thyrotropin receptor antibodies (TSHR); Anti-β2-glycoprotein-I antibodies | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Faeces | Helicobacter pylori antigen |
| Clostridioides difficile toxin | ||
| Urine | Legionella antigen | |
| Streptococcus pneumoniae | ||
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Epstein-Barr virus IgG antibody; Epstein-Barr virus IgM antibody |
| Dengue virus IgG antibody; Dengue virus IgM antibody; Dengue virus NS1 antigen | ||
| Helicobacter pylori | ||
| Measles virus; Varicella zoster virus (VZV) | ||
| Parvovirus IgG antibody; Parvovirus IgM antibody | ||
| Brucella abortus antibody; Brucella melitensis antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Chlamydia trachomatis; Chlamydial spp. IgG antibody; Chlamydial spp. IgM antibody; Herpes simplex virus (HSV); Mycoplasma pneumoniae | ||
| Entamoeba histolytica | ||
| Infectious mononucleosis | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Adenovirus; Rotavirus |
Microbiology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Blood | Bacteria; Cultured pathogens identification; Pathogenic identification and antibiotic susceptibility |
| Cultured pathogens identification | ||
| Isolates | Antibiotic susceptibility | |
| Urine | Bilirubin; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Glucose; Ketones; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Specific gravity; Urobilinogen; pH | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Cervical specimen; Genital swabs; Nasal swabs; Rectal swabs | Streptococcus agalactiae (Streptococcus group B); Methicillin resistant Staphylococcus aureus (MRSA) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Sputum | Mycobacterium tuberculosis |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Ascitic fluid; Aspirates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Gastric lavage; Gastrointestinal fluid; General swabs; Isolates; Lymph node fluid; Other body fluids; Pericardial fluid; Peritoneal fluid; Pus; Respiratory specimens; Skin swabs; Sputum; Tissues; Urine; Wound swabs | Mycobacteria detection |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Blood; Bronchial lavage; Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Hair; Isolates; Nails; Ocular specimens; Plasma; Respiratory specimens; Respiratory swabs; Serum; Skin; Skin scrapings; Sputum; Tissues; Urine; Wound swabs | Fungi identification; Fungi susceptibility |
| Smears | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Amoebae; Ova; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Syphilis Treponema pallidum antibody |
Molecular Pathology
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in-situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in-situ hybridisation techniques | Blood; Bone marrow; Tissues | Cytogenetic analysis and reporting |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Pan-bacterial 16s |
| Faeces | Clostridioides difficile toxin | |
| Campylobacter coli; Campylobacter jejuni; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Shiga toxin | ||
| Genital swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Nasopharyngeal aspirate; Respiratory specimens; Sputum | Mycoplasma pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Bronchoalveolar lavage; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Adenovirus; Enterovirus; Human coronavirus NL63; Human coronavirus 229E; Human coronavirus HKU1; Human coronavirus OC43; Human metapneumovirus; Influenza A virus H1 - 2009 pandemic strain; Influenza A virus H3; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B; Rhinovirus |
| Cervical specimen; Genital swabs | Human papilloma virus (HPV) | |
| Human papilloma virus (HPV) | ||
| Faeces | Norovirus; Rotavirus | |
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Influenza A virus H1 - 2009 pandemic strain; Influenza A virus H1/09; Influenza A virus H3 | |
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Blood | Cytomegalovirus (CMV) viral load |
| Plasma | Epstein-Barr virus viral load | |
| Plasma; Serum | Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load | |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood; Bone marrow | Blood borne tumours |
| Blood borne tumours | ||
| Blood; Bone marrow; Fluids; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Solid tumours | |
| Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | Microsatellite instability analysis | |
| Blood borne tumours; Solid tumours | ||
| Fluids; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Solid tumours | |
| Solid tumours | ||
| Formalin-fixed paraffin-embedded (FFPE) tissues | Solid tumours | |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood; Bone marrow | Blood borne tumours |
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood; Bone marrow; Fluids; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Solid tumours | |
| Blood; Bone marrow; Formalin-fixed paraffin-embedded (FFPE) tissues | Blood borne tumours | |
| Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | Microsatellite instability analysis | |
| Blood borne tumours; Solid tumours | ||
| Fluids; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Solid tumours | |
| Solid tumours | ||
| Formalin-fixed paraffin-embedded (FFPE) tissues | Solid tumours | |
| Solid tumours | ||
| Molecular genetics - Heterozygous loci determinations | Blood | Nucleic acid analysis for specific variants |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | Inherited cancer syndromes |
| Inherited cancer syndromes | ||
| Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | Blood borne tumours; Solid tumours | |
| Molecular genetics - Predictive genetic testing - Targeted genes | Blood | Blood borne tumours |
| Inherited cancer syndromes | ||
| Inherited blood borne tumours | ||
| Inherited cancer syndromes | ||
| Blood borne tumours | ||
| Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | Blood borne tumours; Solid tumours | |
| Microsatellite instability analysis | ||
| Molecular genetics - Screening for an unknown mutation - Targeted genes | Blood | Blood borne tumours |
| Inherited cancer syndromes | ||
| Blood; Bone marrow | Blood borne tumours | |
| Blood borne tumours | ||
| Blood borne tumours | ||
| Blood; Bone marrow; Fluids; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Solid tumours | |
| Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | Blood borne tumours; Solid tumours |
Stem Cell Transplantation
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD16; CD19; CD3; CD4; CD56; CD8 |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Blood; Haemopoietic progenitor cells | Enumeration of CD34+ cells; Storage (includes freezing/thawing) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
17248
Site No.
18921
Print date
11 Dec 2023
END OF SCOPE
